Merck (MRK) earnings in Q4 2025
Merck on Tuesday reported fourth-quarter earnings and revenue that beat estimates due to strong demand for its Keytruda cancer immunotherapy…
Biotechnology and pharmaceuticals
Hims & Hers pulls knockoff weight-loss pill after legal threats
Piotr Swat | Light rocket | fake images him and her on Saturday said it will pull its knock-off weight-loss…
Eli Lilly (LLY) Earnings in Q4 2025
Eli Lilly on Wednesday released fourth-quarter earnings, revenue and 2026 guidance that beat estimates, as demand soars for its blockbuster…
Pfizer executives discuss anti-obesity drug Metsera
Albert Bourla, chairman and CEO of Pfizer, speaks at the Wall Street Journal's Future of Everything festival in New York…
White House launches direct-to-consumer drug site
President Donald Trump makes an announcement from the Oval Office of the White House in Washington, November 6, 2025. Jonathan…
Eli Lilly Wins in LPG-1 Market Over Novo Nordisk, Earnings Show
The Eli Lilly and Novo Nordisk logos. Mike Blake | Little Tom | Reuters It's the story of two drugmakers…
Pfizer's monthly anti-obesity shot shows promise in trial
Smith Collection | Stock Photos | fake images Pfizer on Tuesday said its experimental anti-obesity drug, which it acquired through…
Pfizer (PFE) earnings in the fourth quarter of 2025
Albert Bourla, CEO of Pfizer, speaking at Squawk on the Street at the World Economic Forum in Davos, Switzerland, on…
Eli Lilly CEO David Ricks Discusses Medicare Coverage of Obesity Pills
Eli Lilly Chief Executive Dave Ricks said Friday that upcoming Medicare coverage of obesity drugs could be a major catalyst…
Eli Lilly plans $3.5 billion plant in Pennsylvania for obesity drugs
Eli Lilly Chairman and CEO Dave Ricks speaks during a news conference in Houston, Sept. 23, 2025. Antranik Tavitian |…